title: A nice problem to have: when ALK inhibitor therapy works better than expected.
authors.affiliation: Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine and the University of Colorado Cancer Center, Aurora, Colorado.
authors.forename: Robert C
authors.initials: RC
authors.lastname: Doebele
mesh_terms: D000077548:Anaplastic Lymphoma Kinase; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D011379:Prognosis; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D047428:Protein Kinase Inhibitors; C000626173:ALK protein, human; D000077548:Anaplastic Lymphoma Kinase; D020794:Receptor Protein-Tyrosine Kinases